It has become one of the fastest-growing causes of liver failure and liver transplantation. Many people are living with the ...

Researchers at the University of California San Diego School of Medicine have reported results from a large international ...

July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...

Novo Nordisk said about two in three people in India have fatty liver disease, which offers immense potential for the ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK. Liver fibrosis happens ...

The Global Non-Alcoholic Steatohepatitis Treatment Market is entering its first sustained commercial expansion phase as approved therapies create defined prescription pathways for patients with ...

An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door ...

Emcure's semaglutide brand Poviztra has received CDSCO approval for treating MASH, expanding access to fatty liver treatment ...

Lifestyle changes, medications, and emerging therapies can help treat or reverse metabolic dysfunction-associated steatotic liver disease (MASLD) for some people. Metabolic dysfunction-associated ...

An experimental drug repaired the gut and reversed severe fatty liver disease in animals, opening the door to a promising new ...

If your diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) came as a surprise, you're not alone. Usually, you're diagnosed after a routine blood test shows higher than ...

Alcoholic cirrhosis is the severe, final stage of alcohol-associated liver disease, resulting from long-term heavy alcohol consumption. The disease involves permanent scarring of the liver, which ...